HIF1A and chronic kidney disease: HIF activation through myeloid cell Vhl deletion reduced inflammation in a model of chronic kidney disease, and macrophage HIF-1α deletion increased the immune response to cancer through de-repression of infiltrating cytotoxic T-cell activity [56, 57].